Poziotinib | Interleukin Related interleukin-related.com

Product Name :
Poziotinib

Search keywords :
Poziotinib

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-4

Target Vo Short Name :
HER4

Moa_Name:
Receptor protein-tyrosine kinase erbB-4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Lung Neoplasms

Termination Status :

China Termination Status :
Phase 2 Clinical

Highest Status:
NDA/BLA

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKC beta 1 Antibody
p21 Antibody
GPR30 Antibody: GPR30 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-GPR30 polyclonal antibody. GPR30 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: chicken, cow, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts